Leprosy: why does it persist among us?-Reference-Cited by-同舟云学术

Leprosy: why does it persist among us?

Published:2020-04-17 Issue:7 Volume:18 Page:613-615
ISSN:1478-7210
Container-title:Expert Review of Anti-infective Therapy
language:en
Short-container-title:Expert Review of Anti-infective Therapy

Author:

Santos Victor S.¹,de Souza Carlos D. F.²,Martins-Filho Paulo R. S.³,Cuevas Luis E.⁴

Affiliation:

1. Centre for Epidemiology and Public Health, Federal University of Alagoas, Arapiraca, Brazil

2. Department of Medicine, Federal University of Alagoas, Arapiraca, Brazil

3. Investigative Pathology Laboratory, Federal University of Sergipe, Aracaju, Brazil

4. Department of Clinical Science, Liverpool School of Tropical Medicine, Liverpool, UK

Publisher

Informa UK Limited

Subject

Virology,Infectious Diseases,Microbiology (medical),Microbiology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14787210.2020.1752194

Reference18 articles.

1. Functional Activity Limitation and Quality of Life of Leprosy Cases in an Endemic Area in Northeastern Brazil

2. World Health Assembly. Leprosy resolution WHA 44.9: forty-fourth [Internet]. Geneva; 1991 [cited 2010 Oct 19]. Available from: https://www.who.int/neglected_diseases/mediacentre/resolutions/en/index1.html

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. From Challenges to Solution: The Evolving Landscape of Leprosy Management;Advanced Therapeutics;2024-08-24

2. Buruli ulcer, tuberculosis and leprosy: Exploring the One Health dimensions of three most prevalent mycobacterial diseases: A narrative review;Tropical Medicine & International Health;2024-07-12

3. Factors associated with delayed diagnosis of leprosy in an endemic area in Northeastern Brazil: a cross-sectional study;Cadernos de Saúde Pública;2024

4. Enfrentamento da hanseníase em tempos de COVID-19;Revista Brasileira de Medicina de Família e Comunidade;2023-09-01

5. A Current Perspective on Leprosy (Hansen’s Disease);Vaccines for Neglected Pathogens: Strategies, Achievements and Challenges;2023